Our data suggest that, although EGFR molecular alterations are not as frequent in squamous cell carcinoma as in adenocarcinoma, high expression of this gene occurs in the squamous cell carcinoma and may be the reason for anti-EGFR therapy being efficacious in some squamous cell carcinoma patients [11]. Here, EGFR is linked to adenocarcinoma.